# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-124159
Filing Date
2024-11-08
Accepted
2024-11-08 16:31:36
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tkno-20240930.htm iXBRL | 10-Q | 2035666
2 | EX-31.1 | tkno-ex31_1.htm | EX-31.1 | 16635
3 | EX-31.2 | tkno-ex31_2.htm | EX-31.2 | 16612
4 | EX-32.1 | tkno-ex32_1.htm | EX-32.1 | 15218
| Complete submission text file | 0000950170-24-124159.txt |  | 8477164

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | tkno-20240930.xsd | EX-101.SCH | 1321316
80 | EXTRACTED XBRL INSTANCE DOCUMENT | tkno-20240930_htm.xml | XML | 1379526

Mailing Address 2451 BERT DRIVE HOLLISTER CA 95023
Business Address 2451 BERT DRIVE HOLLISTER CA 95023 8316371100
Alpha Teknova, Inc. (Filer) CIK: 0001850902 (see all company filings)

EIN.: 943368109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40538 | Film No.: 241441158
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)